These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 23541532)
1. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines. Cassel JA; Reitz AB Biochim Biophys Acta; 2013 Jun; 1834(6):964-71. PubMed ID: 23541532 [TBL] [Abstract][Full Text] [Related]
2. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia. Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557 [TBL] [Abstract][Full Text] [Related]
5. Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans. Saxton AD; Kraemer BC G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 33963840 [TBL] [Abstract][Full Text] [Related]
6. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Williams KL; Warraich ST; Yang S; Solski JA; Fernando R; Rouleau GA; Nicholson GA; Blair IP Neurobiol Aging; 2012 Oct; 33(10):2527.e3-10. PubMed ID: 22717235 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function. Cassel JA; McDonnell ME; Velvadapu V; Andrianov V; Reitz AB Biochimie; 2012 Sep; 94(9):1974-81. PubMed ID: 22659571 [TBL] [Abstract][Full Text] [Related]
8. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854 [TBL] [Abstract][Full Text] [Related]
9. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683 [TBL] [Abstract][Full Text] [Related]
11. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Renaud L; Picher-Martel V; Codron P; Julien JP Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation. Xia Y; Yan LH; Huang B; Liu M; Liu X; Huang C J Neurochem; 2014 Apr; 129(1):99-106. PubMed ID: 24215460 [TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1. Peng G; Gu A; Niu H; Chen L; Chen Y; Zhou M; Zhang Y; Liu J; Cai L; Liang D; Liu X; Liu M CNS Neurosci Ther; 2022 Jan; 28(1):105-115. PubMed ID: 34750982 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. Kim SH; Shi Y; Hanson KA; Williams LM; Sakasai R; Bowler MJ; Tibbetts RS J Biol Chem; 2009 Mar; 284(12):8083-92. PubMed ID: 19112176 [TBL] [Abstract][Full Text] [Related]
15. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS. Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404 [TBL] [Abstract][Full Text] [Related]
16. Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia. Gkazi SA; Troakes C; Topp S; Miller JW; Vance CA; Sreedharan J; Al-Chalabi A; Kirby J; Shaw PJ; Al-Sarraj S; King A; Smith BN; Shaw CE Neurobiol Aging; 2019 Jan; 73():229.e5-229.e9. PubMed ID: 30348461 [TBL] [Abstract][Full Text] [Related]
17. ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner. Dao TP; Martyniak B; Canning AJ; Lei Y; Colicino EG; Cosgrove MS; Hehnly H; Castañeda CA Structure; 2019 Jun; 27(6):937-951.e5. PubMed ID: 30982635 [TBL] [Abstract][Full Text] [Related]
18. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Gilpin KM; Chang L; Monteiro MJ Hum Mol Genet; 2015 May; 24(9):2565-77. PubMed ID: 25616961 [TBL] [Abstract][Full Text] [Related]
19. UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis. Daoud H; Suhail H; Szuto A; Camu W; Salachas F; Meininger V; Bouchard JP; Dupré N; Dion PA; Rouleau GA Neurobiol Aging; 2012 Sep; 33(9):2230.e1-2230.e5. PubMed ID: 22560112 [TBL] [Abstract][Full Text] [Related]
20. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Alexander EJ; Ghanbari Niaki A; Zhang T; Sarkar J; Liu Y; Nirujogi RS; Pandey A; Myong S; Wang J Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11485-E11494. PubMed ID: 30442662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]